Orilissa (Elagolix)
- Medicine Name: Orilissa
- Generic Name: Elagolix
- Dosage Form & Strength: Tablets: 150 mg and 200 mg
- Manufactured By: AbbVie
Medical Uses
Orilissa is a gonadotropin-releasing hormone (GnRH) receptor antagonist used for the management of moderate to severe pain associated with endometriosis.
Recommended Dosage: The recommended dosage of Orilissa for normal liver function or mild hepatic impairment is 150 mg once daily for up to 24 months or 200 mg twice daily for up to 6 months. Dosage for moderate hepatic impairment is 150 mg once daily for up to 6 months.
Take Orilissa tablets at around the same time every day, with or without food. Use the lowest effective dose, taking into consideration the severity of symptoms and treatment objectives.
Patients should take a missed dose on the same day as promptly as she remembers and then resume the regular dosing schedule.
Warning & Precautions
- Orilissa may cause a dose-dependent deficiency in bone mineral density (BMD). The BMD loss is higher with increasing time span of use and may not be fully reversible after stopping treatment. This medicine is contraindicated in females with known osteoporosis.
- Women taking Orilissa 150 mg and 200 mg may experience a deficiency in the amount, severity, or term of menstrual bleeding, which may fade the potential to identify the occurrence of a pregnancy in a timely manner. Perform pregnancy testing in case pregnancy is suspected, and discontinue treatment in case of confirmed pregnancy.
- Suicidal behavior/ideation may occur in those treated with Elagolix in the endometriosis clinical studies. Patients should seek prompt medical help for suicidal behavior/ideation. Reevaluate the benefits and risks of continuing this treatment in case such events occur.
- Dose-dependent rises of ALT may occur with Orilissa 200 mg or 150 mg tablets. Quickly evaluate those with elevations in liver tests in order to specify whether the benefits of continued therapy outweigh the risks.
Documentation & Availability
What documents are required to import ORILISSA® to India?
ORILISSA® (elagolix) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is ORILISSA® available in India?
ORILISSA® (elagolix tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
ORILISSA® can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of ORILISSA® (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Orilissa price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the ORILISSA® (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Orilissa®?
Elagolix is a Generic Name for the trade name drug Orilissa®.
What is the Manufacturer’s Name of Orilissa®?
Orilissa is manufactured by AbbVie.
Is Orilissa® approved by the FDA?
Yes, Orilissa® is approved by the FDA. Date of first/initial approval: July 23, 2018.
Where can I get Orilissa® 150 mg at the best price in India?
To get the best Orilissa 150 price in India, kindly connect with S S Healthcare (a WHO GDP and ISO 9001:2008 certified company). For Orilissa® tablets, a valid medical prescription is required from a treating physician.
What is the dosage and form of Orilissa® supplied?
Orilissa is supplied as Tablets: 150 mg and 200 mg for oral administration.
What are the most common side effects of Orilissa®?
The most common side effects of Orilissa® are headache, hot flushes and night sweats, nausea, mood changes, insomnia, anxiety, amenorrhea, arthralgia, and depression-related adverse reactions.
How much does Orilissa® cost in India?
Orilissa cost in India can vary. In order to procure this medication authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Orilissa®?
Store the tablets of Orilissa at a temperature of 2 to 30°C (36 to 86°F).
Is it safe to buy Orilissa® online in India?
Yes, one can buy Orilissa online in India at the best price from the S S Healthcare if the medication Orilissa® is not registered or is unavailable in the respective country. We can facilitate the Import of Orilissa® tablets through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
